HAL (France)open access
Anifrolumab, a potential treatment for ADA2 deficiency
Autoimmune Diseases, 0, Inflammation, 1, Therapeutics, Autoimmunity
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 971128
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.